SE7603554L - Nitrofurylpyrazolderivat och sett for deras framstellning - Google Patents

Nitrofurylpyrazolderivat och sett for deras framstellning

Info

Publication number
SE7603554L
SE7603554L SE7603554A SE7603554A SE7603554L SE 7603554 L SE7603554 L SE 7603554L SE 7603554 A SE7603554 A SE 7603554A SE 7603554 A SE7603554 A SE 7603554A SE 7603554 L SE7603554 L SE 7603554L
Authority
SE
Sweden
Prior art keywords
nitrofurylpyrazole
derivatives
preparation
nitrofurylpyrazole derivatives
Prior art date
Application number
SE7603554A
Other languages
English (en)
Swedish (sv)
Inventor
G Rainer
H Hein
Original Assignee
Byk Gulden Lomberg Chemischi F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU72129A external-priority patent/LU72129A1/xx
Priority claimed from LU74400A external-priority patent/LU74400A1/xx
Application filed by Byk Gulden Lomberg Chemischi F filed Critical Byk Gulden Lomberg Chemischi F
Publication of SE7603554L publication Critical patent/SE7603554L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
    • C07D307/76—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals having carbonic acyl radicals or their thio or nitrogen analogues directly attached to the hydrazino or hydrazono radical, e.g. semicarbazides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7603554A 1975-03-25 1976-03-23 Nitrofurylpyrazolderivat och sett for deras framstellning SE7603554L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU72129A LU72129A1 (ru) 1975-03-25 1975-03-25
LU74400A LU74400A1 (ru) 1976-02-20 1976-02-20

Publications (1)

Publication Number Publication Date
SE7603554L true SE7603554L (sv) 1976-09-26

Family

ID=26640174

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603554A SE7603554L (sv) 1975-03-25 1976-03-23 Nitrofurylpyrazolderivat och sett for deras framstellning

Country Status (12)

Country Link
US (1) US4093812A (ru)
JP (2) JPS51125387A (ru)
AT (1) ATA210876A (ru)
BE (1) BE839932A (ru)
DE (1) DE2612155A1 (ru)
DK (1) DK127876A (ru)
FI (1) FI760765A (ru)
FR (1) FR2305181A1 (ru)
GB (1) GB1507957A (ru)
NL (1) NL7603012A (ru)
NO (1) NO760996L (ru)
SE (1) SE7603554L (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE896678A (fr) * 1982-05-18 1983-11-07 Sandoz Sa Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments.
US4800201A (en) 1984-10-04 1989-01-24 Zenyaku Kogyo Kabushiki Kaisha 1,4-thiazine derivative, and cardiotonic agent comprising it as effective component
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US6749721B2 (en) * 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Process for incorporating poorly substantive paper modifying agents into a paper sheet via wet end addition
WO2004037248A2 (en) * 2002-10-24 2004-05-06 Carex Sa Modulation of peroxisome proliferator activated receptors activity
CA2511646A1 (en) * 2002-12-27 2004-07-22 Chiron Corporation Thiosemicarbazones as anti-virals and immunopotentiators
WO2005061462A2 (en) * 2003-12-19 2005-07-07 Neurogen Corporation Diaryl pyrazole derivatives and their use as neurokinin-3 receptor modulators
US7122700B2 (en) * 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
US7670459B2 (en) * 2004-12-29 2010-03-02 Kimberly-Clark Worldwide, Inc. Soft and durable tissue products containing a softening agent
ES2369389T3 (es) * 2005-04-05 2011-11-30 F. Hoffmann-La Roche Ag 1h-pirazol-4-carboxamidas, su preparación y su empleo como inhibidores de 11-beta- hidroxiesteroide dehidrogenasa.
WO2008021088A2 (en) * 2006-08-08 2008-02-21 The Regents Of The University Of Californina Salicylanilides enhance oral delivery of therapeutic peptides
JP4940999B2 (ja) * 2007-02-28 2012-05-30 株式会社タンガロイ スローアウェイ式切削工具
JP4941082B2 (ja) * 2007-05-08 2012-05-30 株式会社タンガロイ スローアウェイ式切削工具およびこれに装着される切刃チップ
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
MA44674B1 (fr) 2016-04-15 2020-06-30 Abbvie Inc Inhibiteurs de bromodomaine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758050A (fr) * 1969-10-28 1971-04-27 Geigy Ag J R Derives 5-nitro-furyliques et medicaments contenant de tels composes

Also Published As

Publication number Publication date
DE2612155A1 (de) 1976-10-14
JPS5248675A (en) 1977-04-18
JPS6032630B2 (ja) 1985-07-29
DK127876A (da) 1976-09-26
US4093812A (en) 1978-06-06
NL7603012A (nl) 1976-09-28
JPS51125387A (en) 1976-11-01
GB1507957A (en) 1978-04-19
FR2305181A1 (fr) 1976-10-22
NO760996L (ru) 1976-09-28
BE839932A (fr) 1976-09-23
ATA210876A (de) 1979-01-15
FI760765A (ru) 1976-09-26

Similar Documents

Publication Publication Date Title
SE436367B (sv) Mattbana och sett for dess framstellning
SE7602339L (sv) Kinolonderivat och sett att framstella desamma
FI66893C (fi) Saosom faergaemnen anvaendbara biskatjoniska azofoereningar forfarande foer deras framstaellning och deras anvaendning
SE7614218L (sv) Basiskt substituerade indolderivat och forfarande for deras framstellning
SE7603554L (sv) Nitrofurylpyrazolderivat och sett for deras framstellning
SE7506951L (sv) 2-fenyl-indolderivat och sett for framstellning derav
SE7611884L (sv) Triazolderivat och sett for deras framstellning
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
SE7613079L (sv) Alfa-aminoketonderivat och sett for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
FI55018C (fi) Hoeljeaemne saerskilt foer aerosolfoerpackningar och anordning foer aemnets framstaellning medelst kallpressning
SE7613947L (sv) Sekunder eteraminer och forfarande for deras framstellning
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
SE7512447L (sv) Cinnolinderivat och sett for deras framstellning
SE432424B (sv) Halogenerade alkoxisilanforeningar och forfarande for deras framstellning
SE7611504L (sv) Tiazolidinderivat och forfarande for deras framstellning
SE7713958L (sv) Bensimidazolderivat och sett for deras framstellning
SE7607241L (sv) Aralifatiska dihalogenforeningar och forfarande for framstellning derav
SE7600704L (sv) Difenyleter-derivat och forfarande for framstellning derav
SE7609235L (sv) Nya prostanderivat och sett for deras framstellning
SE7614386L (sv) Bensamider och forfarande for framstellning derav
SE7813183L (sv) Naftalenderivat och sett for deras framstellning
SE7604879L (sv) 7-metoxicefalosporinderivat och forfarande for framstellning derav
SE7606282L (sv) Morfolinderivat och sett for deras framstellning
SE7510464L (sv) Cefemderivat och forfarande for framstellning derav